Evaluation of gene expression measurements from commercial microarray platforms

Multiple commercial microarrays for measuring genome‐wide gene expression levels are currently available, including oligonucleotide and cDNA, single‐ and two‐channel formats. This study reports on the results of gene expression measurements generated from identical RNA preparations that were obtaine...

Full description

Saved in:
Bibliographic Details
Published inNucleic acids research Vol. 31; no. 19; pp. 5676 - 5684
Main Authors Tan, Paul K., Downey, Thomas J., Spitznagel Jr, Edward L., Xu, Pin, Fu, Dadin, Dimitrov, Dimiter S., Lempicki, Richard A., Raaka, Bruce M., Cam, Margaret C.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.10.2003
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Multiple commercial microarrays for measuring genome‐wide gene expression levels are currently available, including oligonucleotide and cDNA, single‐ and two‐channel formats. This study reports on the results of gene expression measurements generated from identical RNA preparations that were obtained using three commercially available microarray platforms. RNA was collected from PANC‐1 cells grown in serum‐rich medium and at 24 h following the removal of serum. Three biological replicates were prepared for each condition, and three experimental replicates were produced for the first biological replicate. RNA was labeled and hybridized to microarrays from three major suppliers according to manufacturers’ protocols, and gene expression measurements were obtained using each platform’s standard software. For each platform, gene targets from a subset of 2009 common genes were compared. Correlations in gene expression levels and comparisons for significant gene expression changes in this subset were calculated, and showed considerable divergence across the different platforms, suggesting the need for establishing industrial manufacturing standards, and further independent and thorough validation of the technology.
Bibliography:Received May 23, 2003; Revised July 11, 2003; Accepted August 11, 2003
To whom correspondence should be addressed. Tel: +1 301 594 2493; Fax: +1 301 480 0855; Email: maggiec@intra.niddk.nih.gov
istex:607F09D9861C1F1653C8C025E081414211A73B54
ark:/67375/HXZ-742CFRXH-X
local:gkg763
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0305-1048
1362-4962
1362-4962
DOI:10.1093/nar/gkg763